Press Releases

Perrigo is a leading global consumer-focused self-care company. Our vision is to make lives better by bringing “Quality, Affordable Self-Care Products” that consumers trust everywhere they are sold. The Company is a leading provider of health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed.

Learn More

 

 
Advanced Search
  • Aug 29, 2018
    Perrigo to Reschedule Investor Event

    Perrigo Company plc (NYSE; TASE: PRGO) today announced that it has postponed its investor event to discuss its long-term consumer growth strategies and key operational initiatives, previously...

  • Aug 9, 2018
    Perrigo Expands OTC Growth Strategy With Rx-To-OTC Switch Licensing For Nasonex®
    - Expands Consumer Healthcare Americas growth strategy with innovative offering for an Rx to OTC brand switch and store brand solution

    Perrigo Company plc (NYSE; TASE: PRGO) announced today that it has entered into a licensing agreement with a subsidiary of Merck & Co, Inc., Kenilworth, NJ, USA for the exclusive rights in the...

  • Aug 9, 2018
    Perrigo Announces Plan To Separate Prescription Pharmaceuticals Business

    Perrigo Company plc (NYSE; TASE: PRGO) today announced that its Board of Directors approved a plan to separate the Company's Prescription Pharmaceuticals (Rx) business following the Company's...

  • Aug 9, 2018
    Perrigo Company plc Reports Second Quarter 2018 Financial Results

    Realized second quarter 2018 GAAP ("reported") net sales of $1.2 billion, reported net income of $36 million compared to a net loss of $70 million last year and reported diluted earnings per share...

  • Aug 1, 2018
    Perrigo Announces Quarterly Dividend

    Perrigo Company plc (NYSE; TASE: PRGO) today announced that its Board of Directors declared a quarterly dividend of $0.19 per share, payable on September 18, 2018 to shareholders of record on...

Show 5102550100 per page